期刊
CURRENT GENE THERAPY
卷 7, 期 1, 页码 7-23出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/156652307779940243
关键词
angiogenesis; vascular endothelial growth factor; heme oxygenase; hypoxia inducible factor-1; superoxide dismutase; endothelial progenitor cells
资金
- Wellcome Trust [073974] Funding Source: Medline
Cardiovascular diseases are the major cause of morbidity and mortality in both men and women in industrially developed countries. These disorders may result from impaired angiogenesis, particularly in response to hypoxia. Despite many limitations, gene therapy is still emerging as a potential alternative for patients who are not candidates for traditional revascularization procedures, like angioplasty or vein grafts. This review focuses on recent approaches in the development of new gene delivery vectors, with great respect to newly discovered AAV serotypes and their modified forms. Moreover, some new cardiovascular gene therapy strategies have been highlighted, such as combination of different angiogenic growth factors or simultaneous application of genes and progenitor cells in order to obtain stable and functional blood vessels in ischemic tissue.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据